News from mei pharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 29, 2014, 08:30 ET
MEI Pharma Logo.

MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the...

Sep 18, 2014, 09:00 ET
MEI Pharma Logo. (PRNewsFoto/MEI Pharma, Inc.)

MEI Pharma To Present At BioCentury's NewsMakers Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Sep 09, 2014, 09:00 ET

MEI Pharma Reports Fiscal Year 2014 Results

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced...

Sep 02, 2014, 08:30 ET
MEI Pharma Logo. (PRNewsFoto/MEI Pharma, Inc.)

MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Aug 06, 2014, 09:00 ET
MEI Pharma Logo. (PRNewsFoto/MEI Pharma, Inc.)

MEI Pharma To Present At Wedbush PacGrow Life Sciences And Canaccord Genuity Growth Conferences

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Jun 10, 2014, 08:30 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Reports High Response Rates In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced preliminary...

Jun 09, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma To Present At Wells Fargo Healthcare Conference

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel...

May 08, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma to Present at Bank of America Merrill Lynch and UBS Healthcare Conferences

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel...

May 05, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Initiates Clinical Study Of Mitochondrial Inhibitor Drug Candidate ME-344 In Small Cell Lung And Ovarian Cancers

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Apr 08, 2014, 08:30 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Adds Former VC David Urso as Senior Vice President of Corporate Development and General Counsel

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today the...

Apr 07, 2014, 08:30 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Identifies Potential Biomarker For Pracinostat In Bladder Cancer

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced the presentation...

Apr 01, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma To Present At Needham Healthcare Conference

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Feb 28, 2014, 08:33 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Receives Orphan Status For Lead Drug Candidate Pracinostat For Treatment Of Acute Myeloid Leukemia

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Feb 25, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma To Present At Cowen Health Care And ROTH Conferences

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Jan 14, 2014, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Initiates Phase II Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Dec 05, 2013, 08:30 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma To Host Analyst And Investor Day

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host an Analyst...

Nov 26, 2013, 09:00 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma To Host Annual Meeting Of Stockholders

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, will host its Annual...

Oct 25, 2013, 08:45 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Announces Pricing of Public Offering of Common Stock

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it...

Oct 24, 2013, 16:05 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma Announces Public Offering Of Common Stock

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that...

Oct 21, 2013, 08:30 ET
MEI Pharma Logo.  (PRNewsFoto/Marshall Edwards, Inc.)

MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Preliminary Evidence of Single-Agent Activity in First-in-Human Clinical Study

 MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced results...